Molecular and functional characteristics of a protective human monoclonal antibody to serotype 8 Streptococcus pneumoniae capsular polysaccharide

Infection and Immunity

Volumn 67, Issue 8, 1999, Pages 4119-4127

  Zhong, Z ^a   Burns, T ^a   Chang, Q ^a   Carroll, M ^b   Pirofski, L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; POLYSACCHARIDE;

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL INFECTION; CELL PROTECTION; CELL SURVIVAL; COMPLEMENT ACTIVATION; HIGH RISK POPULATION; IMMUNE RESPONSE; INFECTION RISK; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

EID: 0032802643     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.8.4119-4127.1999     Document Type: Article

References (57)

1. Aaberge, I. S., J. Eng, G. Lermark, and M. Lovik. 1995. Virulence of Streptococcus pneumoniae in mice: a standardized method for preparation and frozen storage of the experimental bacterial inoculum. Microb. Pathog. 18: 141-152.
2. Aaberge, I. S., B. Hvalbye, and M. Lovik. 1996. Enhancement of Streptococcus pneumoniae serotype 6B infection in mice after passive immunization with human serum. Microb. Pathog. 21:125-137.
3. Abadi, J., J. Friedman, R. Jefferis, R. A. Mageed, and L. Pirofski. 1998. Human antibodies elicited by a pneumococcal vaccine express idiotypic determinants indicative of VH3 gene segment usage. J. Infect. Dis. 178:707-716.
4. Adderson, E. E., F. H. Azmi, P. M. Wilson, P. G. Shackelford, and W. L. Carroll. 1993. The human VH3b gene subfamily is highly polymorphic. J. Immunol. 151:800-809.
5. Alonso De Velasco, E., A. F. Verheul, J. Verhoef, and H. Snippe. 1995. Streptococcus pneumoniae: virulence factors, pathogenesis and vaccines. Microbiol. Rev. 59:591-603.
6. Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
7. Bedos, J., S. Chevret, C. Chastang, P. Geslin, B. Regnier, and French Cooperative Pneumococcus Study Group. 1996. Epidemiologic features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: findings of a French survey. Clin. Infect. Dis. 22:63-72.
8. Bjornson, A. B., and J. S. Lobel. 1986. Lack of a requirement for the Fc region of IgG in restoring pneumococcal opsonization via the alternative complement pathway in sickle cell anemia. J. Infect. Dis. 154:760-769.
9. Bjornson, A. B., and J. S. Lobel. 1987. Direct evidence that decreased opsonization of Streptococcus pneumoniae via the alternative complement pathway in sickle cell disease is related to antibody deficiency. J. Clin. Investig. 79:388-398.
10. Boes, M., A. P. Prodeus, T. Schmidt, M. C. Carroll, and J. Chen. 1999. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J. Exp. Med. 188:2381-2386.
11. Brezinschek, H. P., S. J. Foster, R. I. Brezinschek, T. Dorner, R. Domiati-Saad, and P. E. Lipsky. 1997. Analysis of the human VH gene repertoire. J. Immunol. 99:2488-2501.
12. Brown, E. J., S. W. Hosea, C. H. Hammer, G. Burch, and M. M. Frank. 1982. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia. J. Clin. Investig. 69:85-98.
13. Brown, E. J., K. A. Joiner, R. M. Cole, and M. Berger. 1983. Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule. Infect. Immun. 39:403-409.
14. Butler, J. C., J. Hofmann, M. S. Cetron, J. A. Elliott, R. R. Facklam, and R. F. Breiman. 1996. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J. Infect. Dis. 174:986-993.
15. Casadevall, A., and M. D. Scharff. 1994. Serum therapy revisited: animal models of infection and development of passive antibody therapy. Antimicrob. Agents Chemother. 38:1695-1702.
16. Dochez, A. R. 1912. The occurrence and virulence of pneumococci in the circulating blood during lobar pneumonia and the susceptibility of pneumococcus strains to univalent antipneumococcus serum. J. Exp. Med. 16:680-692.
17. Dorner, T., H. P. Brezinschek, R. I. Brezinschek, S. J. Foster, R. Domiati-Saad, and P. E. Lipsky. 1997. Analysis of the frequency and pattern of somatic mutations within nonproductively rearranged human variable heavy chain genes. J. Immunol. 158:2779-2789.
18. Fine, D. P. 1975. Pneumococcal type-associated variability in alternate complement pathway activation. Infect. Immun. 12:772-778.
19. Fisher, M. B., M. Ma, Z. X. Xhou, O. Finco, S. Han, G. Kelsoe, R. G. Howard, T. L. Rothstein, E. Kremmer, F. S. Rosen, and M. C. Carroll. 1996. Regulation of the B cell response to T-dependent antigens by classical pathway of complement. J. Immunol. 15:549-556.
20. Forsgren, A., and P. G. Quie. 1974. Opsonic activity in human serum chelated with ethylene glycoltetra-acetic acid. Immunology 26:1251-1256.
21. Foster, S. J., H. P. Brezinschek, R. I. Brezinschek, and P. E. Lipsky. 1997. Molecular mechanisms and selective influences that shape the kappa gene repertoire of IgM+ B cells. J. Clin. Investig. 99:1614-1627.
22. Goosens, T., U. Klein, and R. Kuppers. 1998. Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease. Proc. Natl. Acad. Sci. USA 95:2463-2468.
23. Hakoda, M., S. Hayashimoto, H. Yamanaka, C. Terai, N. Kamatani, and S. Kashiwazaki. 1994. Molecular basis for the interaction between human IgM and staphylococcal protein A. Clin. Immunol. Immunopathol. 72:394-401.
24. Hosea, S. W., E. J. Brown, and M. M. Frank, 1980. The critical role of complement in experimental pneumococcal sepsis. J. Infect. Dis. 142:903-909.
25. Hostetter, M. K. 1986. Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production. J. Infect. Dis. 153:682-693.
26. Ibrahim, S., I. J. Seppala, H. Sarvas, and O. Makela. 1993. Proportion of protein A bindable molecules in human IgM and IgA antibodies to seven antigens. Microb. Pathog. 15:159-168.
27. Kang, A., D. R. Burton, and R. A. Lerner. 1991. Combinatorial immunoglobulin libraries in phage lambda. Methods Enzymol. 2:111-118.
28. Karray, S., L. Juompan, R. C. Maroun, G. Isenberg, G. J. Silverman, and M. Zouali. 1998. Structural basis of the gp 120 superantigen-binding site on human immunoglobulin. J. Immunol. 161:6681-6688.
29. Klein, U., K. Rajewsky, and R. Kuppers. 1998. Human immunoglobulin (Ig) M+D+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188:1679-1689.
30. Kuhlman, M., K. Joiner, and A. B. Ezekowitz. 1989. The human mannose-binding protein functions as an opsonin. J. Exp. Med. 169:1733-1745.
31. Lucas, A. H., D. M. Granoff, R. E. Mandrell, C. C. Connolly, A. S. Shah, and D. C. Powers. 1997. Oligoclonality of serum immunogiobulin G antibody responses to Streptococcus pneumoniae capsular polysaccharide serotypes 6B, 14, and 23F. Infect. Immun. 65:5103-5109.
32. MacLeod, C. M., R. G. Hodges, M. Heidelberger, and W. G. Bernhard. 1946. Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides. J. Exp. Med. 45:445-465.
33. Matsuda, F., K. Ishii, P. Bourvagnet, K.-I. Kuma, H. Hayashida, T. Miyata, and T. Honjo. 1998. The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. J. Exp. Med. 188:2151-2162.
34. Mond, J. J., A. Lees, and C. M. Snapper. 1995. T cell-independent antigens type 2. Annu. Rev. Immunol. 13:655-692.
35. Musher, D. M., B. Johnson, Jr., and D. A. Watson. 1990. Quantitative relationship between anticapsular antibody measured by enzyme-linked immunosorbent assay or radioimmunoassay and protection of mice against challenge with Streptococcus pneumoniae serotype 4. Infect. Immun. 58: 3871-3876.
36. Musher, D. M., M. J. Luchi, D. A. Watson, R. Hamilton, and R. E. Baughn. 1990. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of absorption of the serum with non-type-specific cell wall polysaccharide. J. Infect. Dis. 161:728-735.
37. Payne, C. M. 1997. Electron microscopy in the diagnosis of infectious diseases, p. 9-34. In D. H. Connor, F. W. Chandler, H. J. Manz, D. A. Schwartz, and E. E. Lack (ed.), Pathology of infectious diseases. Appleton and Lange, Stamford, Conn.
38. Peset Llopis, M. J., G. Harms, M. J. Hardonk, and W. Timens. 1996. Human immune response to pneumococcal polysaccharides: complement-mediated localization preferentially on CD21-positive splenic marginal zone B cells and follicular dendritic cells. J. Allergy Clin. Immunol. 97:1015-1024.
39. Pirofski, L., and A. Casadevall. 1996. Cryptococcus neoformans: paradigm for the role of antihody in immunity. Zentbl. Bakteriol. 284:475-495.
40. Pirofski, L., and A. Casadevall. 1998. The use of licensed vaccines for active immunization of the immunocompromised host. Clin. Microbiol. Rev. 11:1-26.
41. Pirofski, L., R. Lui, M. DeShaw, A. B. Kressel, and Z. Zhong. 1995. Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine. Infect. Immun. 63:3005-3014.
42. 2 fragments administered intranasally. J. Infect. Dis. 173:1123-1128.
43. Randen, L, K. N. Potter, Y. Li, K. M. Thompson, V. Pascual, O. Forre, J. B. Natvig, and J. D. Capra. 1993. Complementarity-determining region 2 is implicated in the binding of slaphylococcal protein A to human immunoglobulin VHIII variable regions. Eur. J. Immunol. 23:2682-2686.
44. Santosham, M., G. R. Reid, J. Almeido-Hill, C. Thompson, M. C. Wolff, and G. R. Siber. 1992. Efficacy of bacterial polysaccharide immune globulin (BPIG) for prevention of bacteremic pneumococcal infections in Apache children. Pediatr. Res. 31:178A.
45. Scott, J. A. G., A. J. Hall, R. Dagan, J. M. S. Dixon, S. J. Eykyn, A. Fenoll, M. Hortal, L. P. Jette, J. H. Jorgensen, F. Lamothe, C. Latorre, J. T. Macfarlane, D. M. Shlaes, L. E. Smart, and A. Taunay. 1996. Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. Clin. Infect. Dis. 22:973-981.
46. Stack, A. M., R. Malley, C. M. Thompson, L. Kobzik, G. R. Siber, and R. A. Saladino. 1998. Minimum protective serum concentrations of pneumococcal anti-capsular antibodies in infant rats. J. Infect. Dis. 177:986-990.
47. Steele, N. P., R. S. Munson, D. M. Granoff, J. E. Cummins, and P. R. Levine. 1984. Antibody-dependent alternative pathway killing of Haemophilus influenzae type b. Infect. Immun. 44:452-458.
48. Steinitz, M., S. Tamir, M. Ferne, and A. Goldfarb. 1986. A protective human monoclonal IgA antibody produced in vitro: anti-pneumococcal antibody engendered by Epstein-Barr virus-immortalized cell line. Eur. J. Immunol. 16:187-193.
49. Suankratay, C., X.-H. Zhang, Y. Zhang, T. F. Lint, and H. Gewurz. 1998. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway. J. Immunol. 160:3006-3013.
50. Tomasz, A. 1997. Antibiotic resistance in Streptococcus pneumoniae. Clin. Infect. Dis. 24(Suppl. 1):S85-S88.
51. Watson, D. A., D. M. Musher, J. W. Jacobson, and J. Verhoef. 1993. A brief history of the pneumococcus in biomedical research: a panoply of scientific discovery. Clin. Infect. Dis. 17:913-924.
52. Wessels, M. R., R. Butko, N. Ma, H. B. Warren, A. L. Lage, and M. C. Carroll. 1995. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. USA 92:11490-11494.
53. Wilson, P. M., O. Bouteiller, Y. J. Liu, K. Potter, J. Banchereau, J. D. Capra, and V. Pascual. 1998. Somatic hypermutation introduces insertions and deletions into immunoglobulin V genes. J. Exp. Med. 187:59-70.
54. Winkelstein, J. A. 1982. Complement and the host's defense against the pneumococcus. Crit. Rev. Microbiol. 11:187-208.
55. Winkelstein, J. A., and H. S. Shin. 1974. The role of immunoglobulin in the interaction of pneumococci and the properdin pathway: evidence for its specificity and lack of requirement for the Fc portion of the molecule. J. Immunol. 112:1635-1642.
56. Zhong, Z., and L. Pirofski. 1998. Antifungal activity of a human antiglucuronoxylomannan antibody. Clin. Lab. Diagn. Immunol. 5:58-64.
57. Zhong, Z., T. Burns, and L. Pirofski. 1999. A human IgM monoclonal antibody prolongs survival of mice with lethal pneumococcal infection, abstr. 617. In Abstracts of the 99th General Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C.